Boston Scientific Corporation (BSX) — Stock Price, Chart & Analysis
Boston Scientific Corporation (BSX) is a Healthcare stock currently trading at $100, up 0.00% on the day. It carries a market capitalization of $65.10B and a trailing P/E ratio of 17.69. Over the past 52 weeks, BSX has traded between $42.20 and $105.65. Boston Scientific Corporation does not currently pay a regular dividend. View the live BSX chart, technical opinion, analyst ratings, fundamentals and latest news below.
Boston Scientific Corporation (BSX) key data
| Price | $100 |
| Change (today) | +0.00% |
| Previous close | $100 |
| Market cap | $65.10B |
| P/E ratio (TTM) | 17.69 |
| EPS (TTM) | $2.54 |
| 52-week high | $105.65 |
| 52-week low | $42.20 |
| Beta | 0.57 |
| Avg. volume | 20.77M |
| Sector | Healthcare |
| Industry | Medical Devices |
Frequently asked questions about Boston Scientific Corporation (BSX)
How much does one share of Boston Scientific Corporation cost?
As of the latest update, one share of Boston Scientific Corporation (BSX) trades at $100 (+0.00% today).
What is Boston Scientific Corporation's market cap?
Boston Scientific Corporation has a market capitalization of approximately $65.10B.
What is Boston Scientific Corporation's P/E ratio?
Boston Scientific Corporation has a trailing price-to-earnings (P/E) ratio of 17.69.
What is Boston Scientific Corporation's earnings per share (EPS)?
Boston Scientific Corporation's trailing twelve-month EPS is $2.54.
Does Boston Scientific Corporation pay a dividend?
Boston Scientific Corporation does not currently pay a regular dividend.
What is Boston Scientific Corporation's 52-week trading range?
Over the past year, BSX has traded between $42.20 and $105.65.
What is the analyst price target for Boston Scientific Corporation?
The mean analyst price target for Boston Scientific Corporation is $61.07. This is informational only and not investment advice.
Latest Boston Scientific Corporation (BSX) news
- How Far Can BSX Stock Swing After Losing More Than Half Its Value?News · Sep 22, 2026
- Interventional Cardiology Devices Market by Type, End User - Global Forecast to 2031News · Sep 18, 2026
- BSX vs. MDT: Which Electrophysiology Stock Is the Better Bet Now?News · Sep 17, 2026
- Citi downgrades Boston Scientific on uncertain recovery pathNews · Sep 17, 2026
- Boston Scientific (BSX) Recalls LUX Dx Cardiac Monitor Over Delayed AF AlertsNews · Sep 17, 2026
- GE Aerospace Goes Vertical (Integration)News · Sep 20, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live BSX dashboard…